NRX Pharmaceuticals, Inc. Warrant
NRXPW
NRXPW
4 hedge funds and large institutions have $2.84K invested in NRX Pharmaceuticals, Inc. Warrant in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.42K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$13 |
Top Sellers
| 1 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$2K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.03K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2.42K | +$2.42K | +13,436 | New |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| $404 | -$1.03K | -5,500 | -72% |
|
|
3
UBS Group
Zurich,
Switzerland
| $13 | +$13 | +69 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $3 | – | – | – |
|
|
YCM
5
Yakira Capital Management
Westport,
Connecticut
| – | -$2K | -15,409 | Closed |
|